Literature DB >> 18890031

The effect of commercial heparin on the platelet count.

E FIDLAR, L B JAQUES.   

Abstract

Entities:  

Keywords:  BLOOD/count; HEPARIN

Mesh：

Substances：

Year:  1948        PMID： 18890031

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  5 in total

1.  The heparin-induced thrombocytopenia and thrombosis syndrome: treatment with intraarterial urokinase and systemic platelet aggregation inhibitors.

Authors:  K D Murphy; G McCrohan; D A DeMarta; N B Shirodkar; O J Kwon; P S Chopra
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Mar-Apr       Impact factor: 2.740

2.  Achieving Long-Term Biocompatible Silicone via Covalently Immobilized S-Nitroso- N-acetylpenicillamine (SNAP) That Exhibits 4 Months of Sustained Nitric Oxide Release.

Authors:  Sean P Hopkins; Jitendra Pant; Marcus J Goudie; Chad Schmiedt; Hitesh Handa
Journal:  ACS Appl Mater Interfaces       Date:  2018-08-01       Impact factor: 9.229

Review 3.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

Review 4.  Heparin-induced thrombocytopenia.

Authors:  B H Chong; M C Berndt
Journal:  Blut       Date:  1989-02

5.  [Influence of five commercial heparin preparations on the collagen induced platelet aggregation (author's transl)].

Authors:  G Kronik; E Deutsch
Journal:  Blut       Date:  1977-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.